Prognostic significance of serum progranulin level in de novo adult acute lymphoblastic leukemia patients
- 31 January 2020
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 20 (2) , 269-276
Abstract
Increased expression of progranulin (PGRN) has been reported in some hematological cancers, but limited information regarding its significance in acute lymphoblastic leukemia (ALL) is available. This study involved 60 subjects (40 de novo adult ALL patients and 20 controls). Serum PGRN level was measured by enzyme-linked immunosorbent assay and was correlated with patient outcome. Serum PGRN level was significantly higher in patients than controls. Serum PGRN level did not correlate with age, total leukocytic count, hemoglobin, platelets, absolute blast count in peripheral blood, lactate dehydrogenase, percent of blasts in bone marrow, gender, comorbidities, the presence of central nervous system infiltration, ALL phenotype, cytogenetics and risk of the disease. High serum PGRN level was not associated with inferior overall survival (OS) on univariate analysis. Regarding cumulative incidence of relapse (CIR) and disease-free survival (DFS), high PGRN level was associated with poor results on univariate analysis. Moreover, it tended to be independent risk factor on multivariate analysis for CIR but was not an independent predictor of inferior DFS. Serum PGRN level is significantly elevated in de novo adult ALL patients and may be used as a predictor of increased relapse risk.Keywords
This publication has 54 references indexed in Scilit:
- Utility of Progranulin and Serum Leukocyte Protease Inhibitor as Diagnostic and Prognostic Biomarkers in Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2013
- Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic LeukemiaPLOS ONE, 2013
- Progranulin as a Prognostic Biomarker for Breast Cancer Recurrence in Patients Who Had Hormone Receptor-Positive Tumors: A Cohort StudyPLOS ONE, 2012
- Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinomaBreast Cancer Research, 2012
- Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in miceJournal of Clinical Investigation, 2011
- Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancersGynecologic Oncology, 2011
- The Granulin-Epithelin Precursor Is a Steroid-Regulated Growth Factor in Endometrical CancerReproductive Sciences, 2006
- PC Cell–Derived Growth Factor Confers Resistance to Dexamethasone and Promotes Tumorigenesis in Human Multiple MyelomaClinical Cancer Research, 2006
- Origins of chromosome translocations in childhood leukaemiaNature Reviews Cancer, 2003
- The Granulin–Epithelin Precursor: A Putative New Growth Factor for Ovarian CancerGynecologic Oncology, 2003